The GenNext Executive Team

Scot R Weinberger

President and CEO

Scot possesses more than thirty years of industrial experience in pioneering and commercializing cutting-edge tools for life science research. A prolific inventor, Scot holds 23 United States Patents for solutions in protein footprinting, liquid chromatography, ultraviolet–visible spectrometry, capillary electrophoresis, time-of-flight mass spectrometry, matrix-assisted laser desorption/ionization, protein biochip technology, tandem mass spectrometry, and surface-tethered and free-solution label-free biosensors. He has authored over thirty scientific publications, six book chapters, and has more than 2,000 citations in the areas of translational medicine, life science research, and technology development. As an entrepreneur, Scot has been on the founding teams of Linear Instruments, Linear Scientific, Biomolecular Separations, Ciphergen Biosystems, and Molecular Sensing. Most recently, Scot founded and launched GenNext Technologies.

Dr. Joshua Sharp

Chief Technology Officer

Josh is a world renowned and internationally recognized expert in HRPF. He has over twenty-one peer-reviewed articles and has presented numerous invited lectures on the subject of biopharmaceutical HRPF. Josh is also an Associate Professor of Pharmacology, Associate Professor of Chemistry and Biochemistry, Director of the Glycoscience Center of Research Excellence at the University of Mississippi.

​Robert Egan

Director of Software Engineering and Development

Bob has over 30 years’ experience of life science software development creating software solutions for: HPLC, HPCE, LCMS, MALDI-TOF, SELDI-TOF MS, FTICR, label-free biosensor (waveguide and interferometry), clinical diagnostics, and HOS analysis.

​Jeffrey Persoff

Senior Scientist

Jeffrey has over thirty years of life science industrial experience developing and commercializing products that utilize or perform interferometry (coherent and diffractive optics), opto-fluidics/biomedical instrument design, ophthalmics, medical imaging, laser surgery, and optical microlithography.

Dr. Emily Chea

Applied Research Scientist

Dr. Emily Chea received her PhD while studying with Professor Dr. Lisa Jones at the University of Maryland, Baltimore. Emily is a highly skilled research scientist in the use of LC-MS techniques for proteomics studies. Emily has made significant contributions to the development of FPOP and HRPF with particular emphasis towards in-cell FPOP (IC-FPOP). Emily focuses on utilizing IC-FPOP for proteome-wide structural biology to characterizing cellular drug–target interactions.

Request a custom HRPF webinar for your lab.

Request Webinar

Discover the Benefits of HRPF

Accelerate biopharmaceutical and biosimilar development and protein conformational research.

Contact Us